Intuitive Surgical ROA 2010-2023 | ISRG
Current and historical return on assets (ROA) values for Intuitive Surgical (ISRG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Intuitive Surgical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $1.80B | $15.44B | 12.59% |
| 2023-09-30 | $1.52B | $14.71B | 11.10% |
| 2023-06-30 | $1.43B | $13.90B | 10.72% |
| 2023-03-31 | $1.31B | $13.05B | 9.90% |
| 2022-12-31 | $1.32B | $12.97B | 9.87% |
| 2022-09-30 | $1.38B | $13.26B | 10.18% |
| 2022-06-30 | $1.44B | $13.71B | 10.66% |
| 2022-03-31 | $1.65B | $13.68B | 12.54% |
| 2021-12-31 | $1.71B | $13.56B | 13.55% |
| 2021-09-30 | $1.69B | $12.94B | 14.09% |
| 2021-06-30 | $1.62B | $12.30B | 14.22% |
| 2021-03-31 | $1.17B | $11.54B | 10.80% |
| 2020-12-31 | $1.06B | $11.17B | 10.16% |
| 2020-09-30 | $1.05B | $10.62B | 10.45% |
| 2020-06-30 | $1.14B | $10.10B | 11.70% |
| 2020-03-31 | $1.39B | $9.89B | 14.88% |
| 2019-12-31 | $1.38B | $9.73B | 15.49% |
| 2019-09-30 | $1.32B | $9.13B | 15.59% |
| 2019-06-30 | $1.21B | $8.53B | 15.17% |
| 2019-03-31 | $1.15B | $8.24B | 15.18% |
| 2018-12-31 | $1.13B | $7.85B | 15.88% |
| 2018-09-30 | $0.80B | $7.32B | 12.19% |
| 2018-06-30 | $0.81B | $6.85B | 13.12% |
| 2018-03-31 | $0.78B | $6.43B | 13.47% |
| 2017-12-31 | $0.67B | $5.78B | 12.49% |
| 2017-09-30 | $0.91B | $5.65B | 16.39% |
| 2017-06-30 | $0.82B | $5.25B | 14.45% |
| 2017-03-31 | $0.78B | $4.81B | 13.47% |
| 2016-12-31 | $0.74B | $6.49B | 12.43% |
| 2016-09-30 | $0.72B | $6.18B | 13.03% |
| 2016-06-30 | $0.68B | $5.78B | 13.12% |
| 2016-03-31 | $0.63B | $5.31B | 13.05% |
| 2015-12-31 | $0.59B | $4.91B | 13.04% |
| 2015-09-30 | $0.55B | $4.68B | 12.76% |
| 2015-06-30 | $0.50B | $4.36B | 12.50% |
| 2015-03-31 | $0.47B | $4.13B | 12.47% |
| 2014-12-31 | $0.42B | $3.96B | 11.02% |
| 2014-09-30 | $0.44B | $3.65B | 11.53% |
| 2014-06-30 | $0.47B | $3.41B | 12.36% |
| 2014-03-31 | $0.53B | $4.19B | 13.12% |
| 2013-12-31 | $0.67B | $3.95B | 16.69% |
| 2013-09-30 | $0.68B | $3.70B | 16.80% |
| 2013-06-30 | $0.71B | $4.20B | 17.40% |
| 2013-03-31 | $0.70B | $4.24B | 17.94% |
| 2012-12-31 | $0.66B | $4.06B | 17.82% |
| 2012-09-30 | $0.63B | $3.73B | 18.41% |
| 2012-06-30 | $0.57B | $3.63B | 17.92% |
| 2012-03-31 | $0.53B | $3.33B | 18.11% |
| 2011-12-31 | $0.49B | $3.06B | 17.92% |
| 2011-09-30 | $0.46B | $2.75B | 17.93% |
| 2011-06-30 | $0.43B | $2.65B | 17.23% |
| 2011-03-31 | $0.40B | $2.57B | 16.79% |
| 2010-12-31 | $0.38B | $2.39B | 16.97% |
| 2010-09-30 | $0.34B | $2.35B | 16.10% |
| 2010-06-30 | $0.32B | $2.24B | 16.45% |
| 2010-03-31 | $0.29B | $2.02B | 16.65% |
| 2009-12-31 | $0.23B | $1.81B | 14.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $132.624B | $7.124B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $208.893B | 25.41 |
| Edwards Lifesciences (EW) | United States | $52.512B | 34.76 |
| DexCom (DXCM) | United States | $51.605B | 88.65 |
| IQVIA Holdings (IQV) | United States | $41.246B | 24.46 |
| IDEXX Laboratories (IDXX) | United States | $39.720B | 47.49 |
| Alcon (ALC) | Switzerland | $38.955B | 28.73 |
| STERIS (STE) | Ireland | $19.787B | 23.42 |
| Waters (WAT) | United States | $18.041B | 25.89 |
| Hologic (HOLX) | United States | $17.586B | 19.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.281B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.132B | 13.75 |
| Sysmex ADR (SSMXY) | Japan | $9.874B | 30.97 |
| Teleflex (TFX) | United States | $9.811B | 15.41 |
| Penumbra (PEN) | United States | $8.077B | 99.85 |
| Masimo (MASI) | United States | $7.229B | 40.54 |
| Globus Medical (GMED) | United States | $6.931B | 21.97 |
| Glaukos (GKOS) | United States | $4.863B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.971B | 25.38 |
| TransMedics (TMDX) | United States | $2.874B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.799B | 18.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.639B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.635B | 18.08 |
| Integra LifeSciences Holdings (IART) | United States | $2.511B | 10.30 |
| Nihon Kohden (NHNKY) | Japan | $2.303B | 19.48 |
| Inari Medical (NARI) | United States | $2.243B | 387.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.050B | 0.00 |
| RxSight (RXST) | United States | $1.954B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.726B | 0.00 |
| Veracyte (VCYT) | United States | $1.416B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.99 |
| Artivion (AORT) | United States | $0.822B | 94.95 |
| Paragon 28 (FNA) | United States | $0.807B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.711B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.704B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.684B | 0.00 |
| SiBone (SIBN) | United States | $0.625B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 18.52 |
| IRadimed (IRMD) | United States | $0.513B | 29.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.451B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.413B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.361B | 0.00 |
| CVRx (CVRX) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.33 |
| AxoGen (AXGN) | United States | $0.303B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.273B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.267B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.254B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.180B | 9.72 |
| Atossa Genetics (ATOS) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.150B | 0.00 |
| Neuronetics (STIM) | United States | $0.119B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.114B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Vasomedical (VASO) | United States | $0.055B | 9.83 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |